Fate Therapeutics
FATE
#7765
Rank
โ‚น19.91 B
Marketcap
โ‚น174.87
Share price
-6.76%
Change (1 day)
-14.36%
Change (1 year)

Fate Therapeutics (FATE) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น25.75 Billion

According to Fate Therapeutics 's latest financial reports the company has โ‚น25.75 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Fate Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚น26.23 B-27.31%
2022-12-31โ‚น36.09 B-21.26%
2021-12-31โ‚น45.84 B29.8%
2020-12-31โ‚น35.31 B123.67%
2019-12-31โ‚น15.79 B12.35%
2018-12-31โ‚น14.05 B118.05%
2017-12-31โ‚น6.44 B2.98%
2016-12-31โ‚น6.25 B45.34%
2015-12-31โ‚น4.30 B38.4%
2014-12-31โ‚น3.11 B-6.78%
2013-12-31โ‚น3.33 B570.97%
2012-12-31โ‚น0.49 B47.26%
2011-12-31โ‚น0.33 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น101.23 B 293.07%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น448.56 B 1,641.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น85.60 B 232.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น109.73 B 326.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น103.73 B 302.78%๐Ÿ‡บ๐Ÿ‡ธ USA